PCNA and neoplasm: Mutations in CTNNB1, which encodes β-catenin, activate the WNT signaling pathway, leading to increased expression of β-catenin, c-Myc, and cyclins, thereby promoting tumor proliferation, migration, and resistance to apoptosis [39].